These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 12461266)
21. VX2 carcinoma in rabbits after radiofrequency ablation: comparison of MR contrast agents for help in differentiating benign periablational enhancement from residual tumor. Kim TJ; Moon WK; Cha JH; Goo JM; Lee KH; Kim KH; Lee JW; Han JG; Weinmann HJ; Chang KH Radiology; 2005 Feb; 234(2):423-30. PubMed ID: 15591437 [TBL] [Abstract][Full Text] [Related]
22. Contrast-enhanced power Doppler sonography and helical computed tomography for assessment of vascularity of small hepatocellular carcinomas before and after percutaneous ablation. Vilana R; Llovet JM; Bianchi L; Sanchez M; Pagés M; Sala M; Gilabert R; Nicolau C; Garcia A; Ayuso C; Bruix J; Bru C; J Clin Ultrasound; 2003; 31(3):119-28. PubMed ID: 12594796 [TBL] [Abstract][Full Text] [Related]
23. Vascularity of hepatocellular carcinoma: assessment with contrast-enhanced second-harmonic versus conventional power Doppler US. Choi BI; Kim TK; Han JK; Kim AY; Seong CK; Park SJ Radiology; 2000 Feb; 214(2):381-6. PubMed ID: 10671584 [TBL] [Abstract][Full Text] [Related]
24. Evaluation using contrast-enhanced harmonic gray scale sonography after radio frequency ablation of small hepatocellular carcinoma: sonographic-histopathologic correlation. Morimoto M; Nozawa A; Numata K; Shirato K; Sugimori K; Kokawa A; Tomita N; Saitou T; Nakatani Y; Imada T; Tanaka K J Ultrasound Med; 2005 Mar; 24(3):273-83. PubMed ID: 15723840 [TBL] [Abstract][Full Text] [Related]
25. Percutaneous US-guided radiofrequency ablation with perfused needle applicators: improved survival with the VX2 tumor model in rabbits. Hänsler J; Neureiter D; Wasserburger M; Janka R; Bernatik T; Schneider T; Müller W; Frieser M; Schaber S; Becker D; Hahn EG; Strobel D Radiology; 2004 Jan; 230(1):169-74. PubMed ID: 14645878 [TBL] [Abstract][Full Text] [Related]
26. [Analysis of vascularity in breast tumors--comparison of high frequency ultrasound and contrast-enhanced color harmonic imaging]. Schröder RJ; Bostanjoglo M; Hidajat N; Rademaker J; Röttgen R; Mäurer J; Felix R Rofo; 2002 Sep; 174(9):1132-41. PubMed ID: 12221572 [TBL] [Abstract][Full Text] [Related]
27. Contrast enhanced ultrasound for radio frequency ablation of canine prostates: initial results. Liu JB; Merton DA; Wansaicheong G; Forsberg F; Edmonds PR; Deng XD; Luo Y; Needleman L; Halpern E; Goldberg BB J Urol; 2006 Oct; 176(4 Pt 1):1654-60. PubMed ID: 16952709 [TBL] [Abstract][Full Text] [Related]
28. Optimal strategies for combining transcatheter arterial chemoembolization and radiofrequency ablation in rabbit VX2 hepatic tumors. Mostafa EM; Ganguli S; Faintuch S; Mertyna P; Goldberg SN J Vasc Interv Radiol; 2008 Dec; 19(12):1740-8. PubMed ID: 18951042 [TBL] [Abstract][Full Text] [Related]
29. Open radio-frequency thermal ablation of renal VX2 tumors in a rabbit model using a cooled-tip electrode: feasibility, safety, and effectiveness. Lee JM; Kim SW; Chung GH; Lee SY; Han YM; Kim CS Eur Radiol; 2003 Jun; 13(6):1324-32. PubMed ID: 12764649 [TBL] [Abstract][Full Text] [Related]
30. Detection of hepatic VX2 tumors in rabbits: comparison of conventional US and phase-inversion harmonic US during the liver-specific late phase of contrast enhancement. Lee JM; Youk JH; Lee YH; Kim YK; Kim CS; Li CA Korean J Radiol; 2003; 4(2):124-9. PubMed ID: 12845308 [TBL] [Abstract][Full Text] [Related]
31. Comparison between color power Doppler ultrasound with echo-enhancer and spiral computed tomography in the evaluation of hepatocellular carcinoma vascularization before and after ablation procedures. Cedrone A; Pompili M; Sallustio G; Lorenzelli GP; Gasbarrini G; Rapaccini GL Am J Gastroenterol; 2001 Jun; 96(6):1854-9. PubMed ID: 11419839 [TBL] [Abstract][Full Text] [Related]
32. Application of radiofrequency ablation of renal VX2 tumors by cooled-tip electrode in a rabbit model. Ho Y; Huang Y; Lin C; Chung C; Lin Y J Endourol; 2009 Apr; 23(4):677-84. PubMed ID: 19335161 [TBL] [Abstract][Full Text] [Related]
33. [Contrast medium supported imaging of tumorous vessels by color Doppler and power Doppler mode in animal experiments]. Graubner T; Fritzsch T; Hauff P; Kaiser WA Rofo; 1996 Dec; 165(6):563-7. PubMed ID: 9026099 [TBL] [Abstract][Full Text] [Related]
35. Intratumoral vascularity of experimentally induced VX2 carcinoma: comparison of color Doppler sonography, power Doppler sonography, and microangiography. Park KS; Choi BI; Won HJ; Seo JB; Kim SH; Kim TK; Han JK; Yeon KM Invest Radiol; 1998 Jan; 33(1):39-44. PubMed ID: 9438508 [TBL] [Abstract][Full Text] [Related]
36. Contrast-enhanced, wide-band, phase inversion harmonic power Doppler imaging of hepatocellular carcinoma. Janica J; Serwatka W; Polaków J; Kordecki K; Łebkowska U; Walecki J; Dobrzycki S Med Sci Monit; 2004 Jun; 10 Suppl 3():32-5. PubMed ID: 16538196 [TBL] [Abstract][Full Text] [Related]
37. Hepatocellular carcinoma: depiction of tumor parenchymal flow with intermittent harmonic power Doppler US during the early arterial phase in dual-display mode. Ding H; Kudo M; Onda H; Suetomi Y; Minami Y; Maekawa K Radiology; 2001 Aug; 220(2):349-56. PubMed ID: 11477236 [TBL] [Abstract][Full Text] [Related]
38. Improved tumor destruction with arsenic trioxide and radiofrequency ablation in three animal models. Hines-Peralta A; Sukhatme V; Regan M; Signoretti S; Liu ZJ; Goldberg SN Radiology; 2006 Jul; 240(1):82-9. PubMed ID: 16720872 [TBL] [Abstract][Full Text] [Related]
39. Evolution of the ablation region after magnetic resonance-guided high-intensity focused ultrasound ablation in a Vx2 tumor model. Wijlemans JW; Deckers R; van den Bosch MA; Seinstra BA; van Stralen M; van Diest PJ; Moonen CT; Bartels LW Invest Radiol; 2013 Jun; 48(6):381-6. PubMed ID: 23399810 [TBL] [Abstract][Full Text] [Related]
40. Percutaneous ablation of malignant liver tumor in rabbits using low radio frequency energy. Nativ O; Moskovitz B; Sabo E; Shalhav A; Kaftori J; Barbara Y; Mordohovich D; Goldwasser B J Exp Ther Oncol; 1996 Sep; 1(5):312-6. PubMed ID: 9414419 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]